| Date Filed | Type | Description |
| 05/16/2023 |
4
| Grais Linda (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $2.45, valued at
$24.5k
|
|
| 04/03/2023 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 800,000 options to buy
@ $0.91, valued at
$728k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 30,000 shares
@ $0.7425, valued at
$22.3k
Bought 4,000 shares
@ $0.841, valued at
$3.4k
|
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 25,000 shares
@ $0.7628, valued at
$19.1k
|
|
| 09/20/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 12,300 shares
@ $0.8101, valued at
$10k
Bought 2,700 shares
@ $0.82, valued at
$2.2k
Bought 5,000 shares
@ $0.815, valued at
$4.1k
|
|
| 08/15/2022 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 160,000 options to buy
@ $0.965, valued at
$154.4k
|
|
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Jones William Benton (See Remarks) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 160,000 options to buy
@ $0.965, valued at
$154.4k
|
|
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $1.6356, valued at
$24.5k
|
|
| 03/17/2022 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 35,160 shares
@ $1.54, valued at
$54.1k
Bought 13,878 shares
@ $1.65, valued at
$22.9k
|
|
| 03/17/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 25,000 shares
@ $1.466, valued at
$36.7k
Bought 5,000 shares
@ $1.59, valued at
$8k
|
|
| 10/01/2021 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Sold 3,000,000 shares
@ $5.0437, valued at
$15.1M
Sold 2,000,000 shares
@ $4.9644, valued at
$9.9M
|
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2021 |
3
| EcoR1 Capital, LLC (10% Owner) has filed a Form 3 on Corvus Pharmaceuticals, Inc. |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 160,000 options to buy
@ $2.6, valued at
$416k
|
|
|